10X Genomics Inc
NASDAQ:TXG

Watchlist Manager
10X Genomics Inc Logo
10X Genomics Inc
NASDAQ:TXG
Watchlist
Price: 22.68 USD 2.86% Market Closed
Market Cap: 2.9B USD

Operating Margin

-21%
Current
Improving
by 10.5%
vs 3-y average of -31.5%

Operating Margin shows how much profit a company makes from its regular business activities after covering operating costs. It helps measure how efficiently the company turns sales into profit.

Operating Margin
-21%
=
Operating Income
$-134.5m
/
Revenue
$641.8m

Operating Margin shows how much profit a company makes from its regular business activities after covering operating costs. It helps measure how efficiently the company turns sales into profit.

Operating Margin
-21%
=
Operating Income
$-134.5m
/
Revenue
$641.8m

Peer Comparison

Country Company Market Cap Operating
Margin
US
10X Genomics Inc
NASDAQ:TXG
2.9B USD
Loading...
US
PerkinElmer Inc
LSE:0KHE
1.3T USD
Loading...
US
Thermo Fisher Scientific Inc
NYSE:TMO
240.3B USD
Loading...
US
Danaher Corp
NYSE:DHR
171B USD
Loading...
CH
Lonza Group AG
SIX:LONN
38.3B CHF
Loading...
US
IQVIA Holdings Inc
NYSE:IQV
41.1B USD
Loading...
CN
WuXi AppTec Co Ltd
SSE:603259
278.3B CNY
Loading...
US
Agilent Technologies Inc
NYSE:A
39.6B USD
Loading...
KR
Samsung Biologics Co Ltd
KRX:207940
83T KRW
Loading...
US
Mettler-Toledo International Inc
NYSE:MTD
29.5B USD
Loading...
FR
Sartorius Stedim Biotech SA
PAR:DIM
19.8B EUR
Loading...
No Stocks Found

Market Distribution

Lower than 77% of companies in the United States of America
Percentile
23rd
Based on 14 112 companies
23rd percentile
-21%
Low
-4 087 900% — -5.1%
Typical Range
-5.1% — 14.8%
High
14.8% — 1 032 600%
Distribution Statistics
the United States of America
Min -4 087 900%
30th Percentile -5.1%
Median 6%
70th Percentile 14.8%
Max 1 032 600%

10X Genomics Inc
Glance View

10X Genomics Inc. stands as a beacon of innovation in the rapidly evolving field of genomics, where the frontier of scientific discovery meets commercial enterprise. Founded in 2012, the company emerged from a vision to delve deeper into the cellular universe, offering tools that illuminate the complexities of biological systems. Nestled in the heart of Silicon Valley, the company has harnessed cutting-edge technology to develop platforms that enable scientists to observe cellular behavior with unprecedented clarity and detail. These tools are particularly vital for understanding the nuances of diseases and developing more targeted therapeutic interventions. At its core, 10X Genomics specializes in creating sophisticated single-cell and spatial analysis solutions, which allow researchers to dissect the minutiae of genetic information within individual cells—an advancement that traditional bulk sequencing techniques simply cannot achieve. This innovative approach is not just a scientific marvel but a robust business model that thrives on the burgeoning demand for advanced genomic research. 10X Genomics generates revenue through a blend of product sales and services. Its primary offerings include instruments and proprietary consumables, such as reagent kits that are fundamental to extracting actionable insights from genomic data. The company’s unique Chromium and Visium platforms are sought after by academic institutions, pharmaceutical companies, and clinical research organizations worldwide. By coupling high-margin consumables with sophisticated hardware, 10X Genomics ensures a recurring revenue stream that supports sustained growth. Meanwhile, it continues to invest heavily in research and development, ensuring its place at the cutting edge of genomic science and maintaining a competitive advantage in a space that demands relentless innovation.

TXG Intrinsic Value
HIDDEN
Show
What is Operating Margin?
Operating Margin shows how much profit a company makes from its regular business activities after covering operating costs. It helps measure how efficiently the company turns sales into profit.
How is Operating Margin calculated?

Operating Margin is calculated by dividing the Operating Income by the Revenue.

Operating Margin
-21%
=
Operating Income
$-134.5m
/
Revenue
$641.8m
What is 10X Genomics Inc's current Operating Margin?

The current Operating Margin for 10X Genomics Inc is -21%, which is above its 3-year median of -31.5%.

How has Operating Margin changed over time?

Over the last 3 years, 10X Genomics Inc’s Operating Margin has increased from -31.9% to -21%. During this period, it reached a low of -40.1% on Jun 30, 2024 and a high of -21% on Oct 30, 2025.

Back to Top